Department of Internal Medicine, University of Michigan Cardiovascular Center, Ann Arbor, MI, USA.
Am J Cardiol. 2013 Apr 16;111(8 Suppl):10C-5C. doi: 10.1016/j.amjcard.2013.01.319.
Survival in patients with pulmonary artery hypertension has improved, but outcomes are still suboptimal. Therapeutic focus must shift from short-term functional changes to improvements in long-term outcomes. Several outcome predictors, both at baseline and on therapy, offer guidance for clinicians treating pulmonary artery hypertension.
肺动脉高压患者的生存率有所提高，但预后仍不理想。治疗重点必须从短期的功能改变转移到长期预后的改善。在基线和治疗过程中有几个预后预测因素，为治疗肺动脉高压的临床医生提供了指导。
